FindTrial
Sign In

Application of droplet digital PCR for monitoring measurable residual disease in pediatric acute myeloid leukemia

Application of droplet digital PCR for monitoring measurable residual disease in pediatric acute myeloid leukemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112079
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-16
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric acute myeloid leukemia

Interventions

MFC MRD group:None
RTqPCR/ddPCR MRD group:None

Sponsors

Children's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Under the age of 18. 2. Diagnosed with acute myeloid leukemia. 3. MRD observation and monitoring were conducted using flow cytometry, real-time fluorescent quantitative PCR or digital PCR, and prognostic follow-up was carried out later.

Exclusion criteria

Exclusion criteria: 1. The patient has acute myeloid leukemia of type AML-M3. 2. Acute mixed phenotype leukemia.

Design outcomes

Primary

MeasureTime frame
MFC MRD;RTqPCR MRD;ddPCR MRD;—

Countries

China

Contacts

Public ContactXiaojun Xu

Children's Hospital, Zhejiang University School of Medicine

xuxiaojun@zju.edu.cn+86 138 5806 7554

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026